Join us Tuesday, July 21, 2026, from 2:30–3:30pm ET for the Foundation’s Annual Public Meeting of the Board of Directors, featuring FDA Acting Commissioner Kyle A. Diamantas, JD
Explore 17 recommendations to modernize IND requirements, streamline Phase 1 clinical trials, & strengthen US leadership in early-stage drug development